Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Bennett Chin

Concepts (282)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiopharmaceuticals
25
2022
158
3.500
Why?
Tomography, Emission-Computed, Single-Photon
19
2014
75
2.360
Why?
Neuroendocrine Tumors
3
2024
85
1.760
Why?
Fluorodeoxyglucose F18
15
2019
115
1.680
Why?
Iodine Radioisotopes
8
2023
126
1.430
Why?
Organometallic Compounds
6
2023
98
1.390
Why?
Positron-Emission Tomography
8
2024
260
1.160
Why?
Tomography, Emission-Computed
9
2004
58
1.110
Why?
Image Enhancement
4
2007
158
0.770
Why?
Heart
8
2014
613
0.690
Why?
3-Iodobenzylguanidine
3
2023
6
0.670
Why?
Fluorine Radioisotopes
3
2017
10
0.640
Why?
Thallium Radioisotopes
5
1999
7
0.580
Why?
Radionuclide Imaging
13
2022
115
0.560
Why?
Contrast Media
6
2014
347
0.550
Why?
Positron Emission Tomography Computed Tomography
5
2022
67
0.540
Why?
Urinary Retention
1
2016
19
0.530
Why?
Carcinosarcoma
1
2016
17
0.530
Why?
Paraganglioma
3
2023
46
0.530
Why?
Leucine
1
2017
102
0.530
Why?
Oxyquinoline
2
2007
3
0.500
Why?
Neoplasms, Second Primary
1
2016
92
0.490
Why?
Carcinoma, Squamous Cell
2
2016
577
0.460
Why?
Whole Body Imaging
2
2014
19
0.440
Why?
Gated Blood-Pool Imaging
2
2007
5
0.440
Why?
Leukemia L1210
2
2012
7
0.440
Why?
Gallium Radioisotopes
2
2023
12
0.430
Why?
Retinal Dehydrogenase
1
2012
33
0.390
Why?
Chloroquine
1
2012
52
0.380
Why?
Myocardial Infarction
3
2007
932
0.380
Why?
Prostatic Neoplasms
3
2016
913
0.380
Why?
Thyroid Neoplasms
3
2016
271
0.380
Why?
Technetium Tc 99m Sestamibi
8
2016
12
0.370
Why?
Phenylalanine
1
2011
57
0.370
Why?
Isoenzymes
1
2012
283
0.360
Why?
Adrenal Gland Neoplasms
3
2023
81
0.350
Why?
Pheochromocytoma
2
2023
54
0.340
Why?
Coronary Circulation
5
2002
134
0.330
Why?
Ventricular Dysfunction, Left
2
2007
371
0.330
Why?
Phantoms, Imaging
7
2015
123
0.330
Why?
Electrocardiography
2
2014
561
0.330
Why?
Tissue Distribution
3
2017
285
0.320
Why?
Sensitivity and Specificity
7
2017
1690
0.310
Why?
Aldehyde Dehydrogenase
1
2009
102
0.310
Why?
Aldehydes
1
2009
138
0.310
Why?
Radiation Dosage
3
2015
133
0.310
Why?
Breast Neoplasms
3
2017
1846
0.310
Why?
Tomography, X-Ray Computed
7
2008
2272
0.290
Why?
Lung Neoplasms
3
2016
2159
0.290
Why?
Image Interpretation, Computer-Assisted
2
2005
224
0.260
Why?
Feasibility Studies
6
2009
735
0.260
Why?
Neoplasm Recurrence, Local
5
2004
850
0.260
Why?
Humans
45
2024
114045
0.250
Why?
Bone Marrow Cells
1
2007
266
0.250
Why?
Bone Marrow Transplantation
1
2007
237
0.250
Why?
Gamma Cameras
1
2005
7
0.250
Why?
Radiometry
2
2017
41
0.250
Why?
Gastrointestinal Neoplasms
1
2006
59
0.250
Why?
Stomach Neoplasms
2
2022
65
0.240
Why?
Intercostal Muscles
1
2004
3
0.240
Why?
Indium Radioisotopes
3
1999
13
0.230
Why?
Somatostatin
3
2016
52
0.230
Why?
Data Curation
1
2024
11
0.230
Why?
Vocal Cord Paralysis
1
2003
21
0.220
Why?
Vocal Cords
1
2003
25
0.220
Why?
Thyrotropin
1
2004
100
0.220
Why?
Mesenchymal Stem Cell Transplantation
1
2003
37
0.220
Why?
Digestive System Neoplasms
1
2003
8
0.220
Why?
Carcinoma, Papillary
1
2003
74
0.210
Why?
Magnetic Resonance Imaging
8
2022
3039
0.210
Why?
Atherosclerosis
1
2007
342
0.210
Why?
Fallopian Tube Neoplasms
1
2002
14
0.210
Why?
Myocardial Contraction
2
2002
318
0.210
Why?
Cell Line, Tumor
3
2017
2700
0.200
Why?
Animals
18
2019
31565
0.200
Why?
Radioisotopes
1
2022
28
0.200
Why?
Receptors, Peptide
1
2022
15
0.200
Why?
Paraganglioma, Extra-Adrenal
1
2022
6
0.200
Why?
Myocardial Stunning
1
2002
5
0.200
Why?
Dobutamine
1
2002
33
0.200
Why?
Intestinal Neoplasms
1
2022
24
0.200
Why?
Mice
8
2019
14843
0.190
Why?
Female
27
2018
59324
0.170
Why?
Oxygen Consumption
1
2003
587
0.170
Why?
Technetium Tc 99m Aggregated Albumin
2
1999
6
0.170
Why?
Leukoencephalopathy, Progressive Multifocal
1
1999
38
0.160
Why?
Stem Cells
1
2003
541
0.160
Why?
Middle Aged
19
2016
26605
0.160
Why?
Cardiac Surgical Procedures
1
2003
414
0.160
Why?
Image Processing, Computer-Assisted
4
2024
684
0.160
Why?
Ventilation-Perfusion Ratio
1
1999
9
0.160
Why?
Receptors, Somatostatin
1
1999
24
0.160
Why?
Thymus Neoplasms
1
1999
20
0.160
Why?
Thymoma
1
1999
29
0.160
Why?
Hormone Antagonists
1
1999
33
0.160
Why?
Radiation Pneumonitis
1
1999
24
0.160
Why?
AIDS-Related Opportunistic Infections
1
1999
115
0.160
Why?
Pancreatic Neoplasms
2
2022
721
0.160
Why?
Male
24
2018
55396
0.150
Why?
Neoplasms
1
2012
2086
0.150
Why?
Metal Nanoparticles
1
2019
69
0.150
Why?
Brain Neoplasms
2
2019
966
0.150
Why?
Amyotrophic Lateral Sclerosis
1
1998
60
0.150
Why?
Sodium Pertechnetate Tc 99m
1
1997
6
0.150
Why?
Myocardium
1
2003
911
0.150
Why?
Coronary Disease
2
2000
348
0.150
Why?
Head and Neck Neoplasms
1
2022
427
0.150
Why?
Frontal Lobe
1
1998
141
0.150
Why?
Dipyridamole
2
2002
25
0.150
Why?
Hematoma
1
1997
50
0.140
Why?
Isotope Labeling
2
2011
67
0.140
Why?
Smoking
1
2004
1382
0.140
Why?
Transurethral Resection of Prostate
1
2016
3
0.140
Why?
Safety
1
2018
298
0.130
Why?
Diagnostic Imaging
1
2019
278
0.130
Why?
Dementia
1
1998
186
0.130
Why?
Vasodilator Agents
2
2002
302
0.130
Why?
Molecular Structure
1
2017
434
0.120
Why?
Parathyroid Diseases
1
2015
1
0.120
Why?
Thyroid Nodule
1
2016
45
0.120
Why?
Sarcoidosis
1
1997
133
0.120
Why?
Stroke Volume
2
1997
513
0.120
Why?
Four-Dimensional Computed Tomography
1
2015
25
0.120
Why?
Ventricular Function, Right
1
1997
256
0.120
Why?
Androstenes
1
2015
11
0.120
Why?
Phenylthiohydantoin
1
2015
40
0.120
Why?
Neoplasms, Radiation-Induced
1
2015
66
0.120
Why?
Taxoids
1
2015
93
0.120
Why?
Prostatic Neoplasms, Castration-Resistant
1
2015
40
0.120
Why?
Dogs
4
2003
331
0.120
Why?
Mediastinum
1
2014
20
0.110
Why?
Mice, Inbred BALB C
1
2017
1144
0.110
Why?
Prednisone
1
2015
229
0.110
Why?
Ventricular Function, Left
1
1997
477
0.110
Why?
Cardiomyopathies
1
1997
298
0.110
Why?
Coronary Stenosis
3
2002
39
0.110
Why?
Bone and Bones
3
2009
277
0.110
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2014
98
0.110
Why?
Healthy Volunteers
1
2014
191
0.110
Why?
Adult
12
2014
30375
0.100
Why?
Aged
11
2015
18969
0.100
Why?
Swine
6
2003
687
0.090
Why?
Carbon Radioisotopes
1
2011
36
0.090
Why?
Hemodynamics
1
1996
1015
0.090
Why?
Drug Resistance, Neoplasm
2
2015
636
0.090
Why?
Time Factors
2
2014
6077
0.090
Why?
Neoplasm Metastasis
2
2004
521
0.090
Why?
Lymph Nodes
2
2003
415
0.090
Why?
Organ Specificity
2
2019
266
0.090
Why?
Reproducibility of Results
3
2007
2764
0.090
Why?
Thyroid Gland
2
2016
85
0.090
Why?
Mice, Nude
1
2012
628
0.090
Why?
Gadolinium
4
2002
73
0.080
Why?
K562 Cells
1
2009
73
0.080
Why?
Mice, Inbred C57BL
3
2007
4680
0.080
Why?
Glioblastoma
1
2012
250
0.080
Why?
Blotting, Western
1
2012
1143
0.080
Why?
Metabolic Clearance Rate
1
2008
102
0.080
Why?
Parathyroid Neoplasms
2
1997
13
0.070
Why?
Neoplasm Staging
2
2002
1162
0.070
Why?
Octreotide
2
1999
25
0.070
Why?
Adenoma
3
1998
187
0.070
Why?
Antineoplastic Agents
2
2015
1875
0.070
Why?
Drug Delivery Systems
1
2009
295
0.070
Why?
Retrospective Studies
5
2016
12521
0.070
Why?
Injections, Intravenous
2
2003
198
0.070
Why?
Analysis of Variance
1
2008
1218
0.060
Why?
Molecular Probe Techniques
1
2005
9
0.060
Why?
Miniaturization
1
2005
23
0.060
Why?
Molecular Biology
1
2005
56
0.060
Why?
Iodides
1
2004
6
0.060
Why?
Equipment Failure Analysis
1
2005
132
0.060
Why?
Biomarkers, Tumor
2
2023
1032
0.060
Why?
Theophylline
1
2004
60
0.060
Why?
Phosphodiesterase Inhibitors
1
2004
82
0.060
Why?
Models, Animal
2
2003
340
0.060
Why?
Thyroglobulin
1
2004
17
0.060
Why?
Artifacts
1
2004
114
0.050
Why?
Equipment Design
1
2005
503
0.050
Why?
Neck
1
2003
85
0.050
Why?
Metanephrine
1
2023
2
0.050
Why?
Inhalation
1
2003
26
0.050
Why?
Exhalation
1
2003
34
0.050
Why?
Gadolinium DTPA
1
2002
47
0.050
Why?
Chromogranin A
1
2023
39
0.050
Why?
Aged, 80 and over
4
2015
6306
0.050
Why?
Movement
1
2004
242
0.050
Why?
Clinical Trials as Topic
1
2006
926
0.050
Why?
Myocardial Ischemia
1
2002
239
0.050
Why?
Intestines
1
2004
325
0.040
Why?
Mice, Knockout
1
2007
2562
0.040
Why?
Recombinant Proteins
1
2004
1228
0.040
Why?
Radioimmunodetection
1
1999
1
0.040
Why?
Esophageal Neoplasms
1
2003
270
0.040
Why?
Lymphocyte Activation
1
2003
1036
0.040
Why?
Cell Movement
1
2003
863
0.040
Why?
Bone Neoplasms
2
1999
191
0.040
Why?
Pilot Projects
1
2003
1360
0.040
Why?
Organotechnetium Compounds
1
1998
10
0.040
Why?
Salvage Therapy
1
1999
127
0.040
Why?
Pleural Neoplasms
1
1999
18
0.040
Why?
Optical Imaging
1
2019
52
0.040
Why?
Mediastinal Neoplasms
1
1999
32
0.040
Why?
Gardner Syndrome
1
1998
2
0.040
Why?
Osteoma
1
1998
2
0.040
Why?
Prostate-Specific Antigen
2
2015
150
0.040
Why?
Gold
1
2019
102
0.040
Why?
Retroperitoneal Space
1
1997
14
0.040
Why?
HIV-1
1
2003
768
0.040
Why?
Cysteine
1
1998
171
0.040
Why?
Carcinoid Tumor
1
1997
23
0.040
Why?
Duodenal Neoplasms
1
1997
19
0.040
Why?
Cardiac Volume
1
1997
11
0.040
Why?
Disease Models, Animal
1
2007
3498
0.040
Why?
Ventricular Function
1
1997
57
0.030
Why?
Colorectal Neoplasms
1
2003
592
0.030
Why?
HEK293 Cells
1
2019
590
0.030
Why?
Cerebrovascular Circulation
1
1998
219
0.030
Why?
Pulmonary Embolism
1
1999
180
0.030
Why?
Choristoma
1
1996
21
0.030
Why?
Magnetic Resonance Imaging, Cine
1
1997
172
0.030
Why?
Incidental Findings
1
2016
70
0.030
Why?
Deoxyglucose
1
1995
43
0.030
Why?
Thoracic Neoplasms
1
1995
31
0.030
Why?
Survival Analysis
1
2018
1206
0.030
Why?
Lung
2
1999
3521
0.030
Why?
Radiography
2
2015
803
0.030
Why?
Abiraterone Acetate
1
2015
14
0.030
Why?
Kallikreins
1
2015
28
0.030
Why?
Diagnosis, Differential
1
1999
1331
0.030
Why?
Nitriles
1
2015
149
0.030
Why?
Benzamides
1
2015
168
0.030
Why?
Risk Factors
3
2015
8614
0.030
Why?
Follow-Up Studies
2
1999
4392
0.030
Why?
Exercise Test
1
1996
547
0.030
Why?
Antibodies, Monoclonal
1
1999
1257
0.030
Why?
Infusions, Intra-Arterial
1
1993
46
0.030
Why?
Infusion Pumps, Implantable
1
1993
20
0.030
Why?
Disease-Free Survival
1
2015
618
0.030
Why?
Treatment Outcome
2
2018
9049
0.030
Why?
Hepatic Artery
1
1993
49
0.030
Why?
Erythrocytes
1
1997
568
0.030
Why?
Kaplan-Meier Estimate
1
2015
813
0.030
Why?
Cardiac Catheterization
1
1996
545
0.030
Why?
Biopsy
1
2016
1024
0.030
Why?
Proportional Hazards Models
1
2015
1078
0.020
Why?
Prognosis
1
1999
3315
0.020
Why?
Carcinoma, Non-Small-Cell Lung
1
1999
959
0.020
Why?
Prevalence
1
2016
2247
0.020
Why?
HIV Infections
1
2003
2453
0.020
Why?
Case-Control Studies
1
1996
3003
0.020
Why?
Incidence
1
2015
2314
0.020
Why?
Brain
1
1999
2355
0.020
Why?
Disease Progression
1
2015
2371
0.020
Why?
Risk Assessment
1
2015
2958
0.020
Why?
Adolescent
2
2018
17800
0.010
Why?
Abdominal Neoplasms
1
2004
26
0.010
Why?
Subtraction Technique
1
2004
24
0.010
Why?
Cyclic AMP
1
2004
225
0.010
Why?
Diagnostic Errors
1
2004
150
0.010
Why?
HIV Seropositivity
1
2003
109
0.010
Why?
Viremia
1
2003
122
0.010
Why?
Drug Evaluation, Preclinical
1
2002
159
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
924
0.010
Why?
Virus Replication
1
2003
395
0.010
Why?
Coronary Vessels
1
2002
234
0.010
Why?
Vasodilation
1
2002
418
0.010
Why?
Angioplasty, Balloon, Coronary
1
2000
146
0.010
Why?
Prostatectomy
1
1999
97
0.010
Why?
Intestinal Mucosa
1
2004
532
0.010
Why?
Influenza Vaccines
1
2003
497
0.010
Why?
Zollinger-Ellison Syndrome
1
1997
2
0.010
Why?
Gastrins
1
1997
8
0.010
Why?
Radionuclide Angiography
1
1997
2
0.010
Why?
Cells, Cultured
1
2004
3861
0.010
Why?
Research Design
1
2002
919
0.010
Why?
Esophagus
1
1996
224
0.010
Why?
Heart Diseases
1
1997
329
0.010
Why?
Technetium
1
1993
8
0.010
Why?
Microspheres
1
1993
123
0.010
Why?
Liver
1
1993
1633
0.000
Why?
Prospective Studies
1
1993
6195
0.000
Why?
Chin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)